Precision BioSciences Stock (NASDAQ:DTIL)
Previous Close
$6.50
52W Range
$6.41 - $19.43
50D Avg
$8.67
200D Avg
$10.60
Market Cap
$55.69M
Avg Vol (3M)
$74.87K
Beta
1.69
Div Yield
-
DTIL Company Profile
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Les Laboratoires Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
DTIL Performance
Peer Comparison
Ticker | Company |
---|---|
PLRX | Pliant Therapeutics, Inc. |
XFOR | X4 Pharmaceuticals, Inc. |
DYN | Dyne Therapeutics, Inc. |
RVMD | Revolution Medicines, Inc. Warrant |
MREO | Mereo BioPharma Group plc |
DAWN | Day One Biopharmaceuticals, Inc. |
STOK | Stoke Therapeutics, Inc. |
HOOK | HOOKIPA Pharma Inc. |
ALEC | Alector, Inc. |
BDTX | Black Diamond Therapeutics, Inc. |
TERN | Terns Pharmaceuticals, Inc. |
PASG | Passage Bio, Inc. |
INZY | Inozyme Pharma, Inc. |
ELDN | Eledon Pharmaceuticals, Inc. |
ABOS | Acumen Pharmaceuticals, Inc. |
CYTK | Cytokinetics, Incorporated |